S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
SWOG Cancer Research Network
Albert Einstein College of Medicine
Ataturk University
M.D. Anderson Cancer Center
Canadian Cancer Trials Group
Wake Forest University Health Sciences
GlaxoSmithKline
Royal Marsden NHS Foundation Trust
OHSU Knight Cancer Institute
Beth Israel Medical Center
National Cancer Institute (NCI)
Northwestern University
City of Hope Medical Center